Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1898 1
1926 2
1946 1
1947 1
1948 2
1954 1
1955 4
1956 4
1957 2
1958 5
1959 1
1960 5
1961 1
1962 7
1963 12
1964 18
1965 9
1966 6
1967 9
1968 14
1969 17
1970 25
1971 22
1972 36
1973 39
1974 36
1975 30
1976 32
1977 29
1978 27
1979 31
1980 29
1981 33
1982 38
1983 37
1984 28
1985 29
1986 34
1987 27
1988 25
1989 36
1990 34
1991 34
1992 29
1993 41
1994 40
1995 42
1996 29
1997 33
1998 24
1999 62
2000 50
2001 65
2002 61
2003 68
2004 71
2005 83
2006 107
2007 108
2008 133
2009 143
2010 143
2011 203
2012 272
2013 284
2014 311
2015 341
2016 321
2017 370
2018 391
2019 456
2020 559
2021 664
2022 683
2023 676
2024 679
2025 689
2026 350

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,395 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ing h[au] (64 results)?
Global, regional, and national burden of headache disorders, 1990-2021, with forecasts to 2050: A Global Burden of Disease study 2021.
GBD 2021 Headache Collaborators. Electronic address: yonkkang@gmail.com; Wijeratne T, Oh J, Kim S, Yim Y, Kim MS, Shin JI, Oh YS, Jung R, Kim YS, Smith L, Aalruz H, Abd-Rabu R, Abdulah DM, Aboagye RG, Abolmaali M, Abtahi D, Abualhasan A, Adedoyin RA, Adnani QES, Afrashteh F, Aggarwal N, Ahmad D, Ahmadi A, Ahmadi NS, Ahmadzade AM, Ahmed SA, Al Awaidy S, Alabbad S, Alajlani MM, Al-Ajlouni Y, Ali MU, Ali SS, Ali W, Almazan JU, Alshahrani NZ, Altaf A, Al-Wardat M, Alzoubi KH, Amiri S, Amu H, Amusa GA, Anderson DB, Anwar S, Areda D, Asghari-Jafarabadi M, Ashina S, Ashraf J, Ashraf T, Azargoonjahromi A, Bahurupi Y, Baig AA, Bandyopadhyay S, Bardhan M, Barqawi HJ, Bashiri A, Bastan MM, Bemanalizadeh M, Bensenor IM, Berhie AYY, Bhagavathula AS, Bhaskar S, Bhat V, Bhatti GK, Bhatti JS, Bilgin C, Biswas A, Bizzozero-Peroni B, Bustanji Y, Cámera LA, Caronna E, Carvalho AF, Chakraborty S, Ching PR, Christodoulou N, Chu DT, Chu H, Cruz-Martins N, Dadras O, Dai X, D'Amico E, Darwish AH, Deekonda S, Devanbu VGC, Dharmaratne SD, Dima A, Dinkayehu TE, Do H, Doku PN, Doshi OP, E'mar AR, Eissazade N, Eltaha C, Fahim A, Fares J, Farjoud Kouhanjani M, Faro A, Fazeli P, Fereshtehnejad SM, Ferrara P, Fe… See abstract for full author list ➔ GBD 2021 Headache Collaborators. Electronic address: yonkkang@gmail.com, et al. Among authors: singh h. Cell Rep Med. 2025 Oct 21;6(10):102348. doi: 10.1016/j.xcrm.2025.102348. Epub 2025 Sep 18. Cell Rep Med. 2025. PMID: 40972580 Free PMC article.
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.
Knox JJ, O'Kane G, King D, Laheru D, Habowski AN, Yu K, Perez K, Aguirre AJ, Coyne Z, Harvey H, McLaughlin RA, Jang RW, Grant RC, Elimova EC, Renouf DJ, Fischer S, Duan K, Ramotar S, Jang GH, Zhang A, Devoe CE, Singh H, Pishvaian MJ, Froeling FEM, Saif MW, O'Reilly EM, Tsang ES, Wolpin BM, Wilson JM, Dodd A, Pugh TJ, Ye XY, Gallinger S, Tuveson DA, Notta F, Jaffee EM. Knox JJ, et al. Among authors: singh h. J Clin Oncol. 2025 Nov;43(31):3355-3368. doi: 10.1200/JCO-25-00436. Epub 2025 Sep 10. J Clin Oncol. 2025. PMID: 40929627 Clinical Trial.
Quo Vadis?
Ghazi N, Singh H, Longbottom E, Hayes SJ, Farnell D, Dutta A. Ghazi N, et al. Among authors: singh h. Int Endod J. 2026 May 11. doi: 10.1111/iej.70177. Online ahead of print. Int Endod J. 2026. PMID: 42109007 No abstract available.
Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease.
Valenzi E, Jia M, Gerges P, Fan J, Tabib T, Behera R, Mao H, Xue D, Ju EM, Zhou Y, Sembrat JC, Das J, Benos PV, Singh H, Lafyatis R. Valenzi E, et al. Among authors: singh h. Ann Rheum Dis. 2025 Dec 31:S0003-4967(25)04598-4. doi: 10.1016/j.ard.2025.12.003. Online ahead of print. Ann Rheum Dis. 2025. PMID: 41478761 Free PMC article.
Epidermal resident memory T cell fitness requires antigen encounter in the skin.
Weiss ES, Hirai T, Li H, Liu A, Baker S, Magill I, Gillis J, Zhang YR, Ramcke T, Kurihara K; ImmGen Consortium OpenSource T cell Project; Masopust D, Anandasabapathy N, Singh H, Zemmour D, Mackay LK, Kaplan DH. Weiss ES, et al. Among authors: singh h. Elife. 2025 Dec 30;14:RP107096. doi: 10.7554/eLife.107096. Elife. 2025. PMID: 41468295 Free PMC article.
Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer.
Kureshi CTS, Walsh MJ, Kureshi R, Cardot-Ruffino V, Agardy DA, Ali LR, Dougan JM, Qiang L, Shen J, Zuo C, Lenehan PJ, Wang SJ, Chang E, Remland J, Brais L, Clancy TE, Cleary JM, Hornick JL, Huffman BM, Mancias JD, Molina G, Fairweather M, Nowak JA, Perez KJ, Rubinson DA, Slater S, van Dams R, Wang J, Wolpin BM, Zhao L, Barrientos K, Novosiadly R, Broz M, Singh H, Dougan M, Dougan SK. Kureshi CTS, et al. Among authors: singh h. Cancer Cell. 2026 May 7:S1535-6108(26)00216-3. doi: 10.1016/j.ccell.2026.04.005. Online ahead of print. Cancer Cell. 2026. PMID: 42102812 Free article.
Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.
Wood-Trageser MA, Nichols CT, Hutchings DA, Bell D, Wald AI, Smith K, Hong SM, Luchini C, Brosens LAA, Verschuur AVD, Bevere M, Lawlor RT, Scarpa A, Keating S, Tucker J, O'Sullivan RJ, Liu TC, McGrath K, Fasanella K, Brand RE, Lennon AM, Das R, Singh H, Slivka A, Mahmood S, Hosmer AE, Khalid A, Romutis SL, Zureikat AH, Zeh HJ, Hogg ME, Lee KK, Paniccia A, Nunns G, Ongchin M, Park WG, Polanco PM, He J, Simeone DM, Ferrone CR, Hsu D, Zhang J, Gorantla V, Rhee J, Hruban RH, Singhi AH, Singhi SA, Wang CK, Shaker N, Bubar R, Grupillo M, Lai YT, Nikiforova MN, Heaphy CM, Waters KM, Singhi AD. Wood-Trageser MA, et al. Among authors: singh h. Mod Pathol. 2025 Oct;38(10):100863. doi: 10.1016/j.modpat.2025.100863. Epub 2025 Aug 8. Mod Pathol. 2025. PMID: 40784487 Free article.
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.
Surana R, Morgado M, Somasundaram A, Bockorny B, Weekes CD, Coleman EC, Bird A, Wang J, Williams HL, Zheng H, Brais LK, Saxena N, Graham C, Ritterband L, Sawin M, Peters ML, Whooley P, Bullock A, Zerillo J, Sanoff HK, Clark JW, Parikh AR, Yurgelun MB, Patel AK, Mayer RJ, Cleary JM, Enzinger P, Rubinson DA, McCleary NJ, Enzinger A, Slater S, Ng K, Biller LH, Abrams TA, Huffman BM, Singh H, Raghavan S, Mancias JD, Bryant KL, Nowak JO, Aguirre AJ, Der CJ, Wolpin BM, Perez K. Surana R, et al. Among authors: singh h. JCO Precis Oncol. 2025 Sep;9:e2500332. doi: 10.1200/PO-25-00332. Epub 2025 Sep 2. JCO Precis Oncol. 2025. PMID: 40893054 Clinical Trial.
8,395 results